v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 32,904 $ 40,921
Accounts receivable, net of allowance for doubtful accounts of $5 in 2025 and $1 in 2024 72 4,452
Commissions receivable - current 239,644 320,399
Prepaid expense and other current assets 13,168 34,639
Total current assets 285,788 400,411
Commissions receivable - non-current 685,527 733,161
Operating lease ROU asset 9,621 19,317
Property, equipment, and capitalized software, net 5,147 29,320
Intangible assets, net 0 302,497
Other long-term assets 1,297 3,717
Total assets 987,380 1,488,423
Current liabilities:    
Accounts payable 6,924 14,591
Accrued liabilities 34,647 121,346
Commissions payable - current 63,947 98,771
Short-term operating lease liability 7,160 5,705
Deferred revenue 25,493 53,720
Current portion of long-term debt 0 39,500
Other current liabilities 3,329 4,419
Total current liabilities 141,500 338,052
Non-current liabilities:    
Commissions payable - non-current 156,532 177,656
Long-term operating lease liability 28,694 34,900
Long-term debt, net of current portion 636,740 447,865
Deferred tax liability 18,588 22,350
Other non-current liabilities 10,645 9,200
Total non-current liabilities 851,199 691,971
Commitments and Contingencies (Note 12)
Stockholders’ equity (Deficit):    
Preferred stock 0 0
Additional paid-in capital 727,635 669,346
Accumulated other comprehensive income (loss) (59) (151)
Accumulated deficit (680,334) (423,208)
Total stockholders’ equity attributable to GoHealth, Inc. 37,873 241,839
Non-controlling interests (100,078) 163,599
Total stockholders’ equity (deficit) (62,205) 405,438
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) 987,380 1,488,423
Series A redeemable convertible preferred stock    
Non-current liabilities:    
Series A redeemable convertible preferred stock — $0.0001 par value; 50 shares authorized; 50 shares issued and outstanding as of both December 31, 2025 and December 31, 2024. Liquidation preference of $58.5 million and $54.6 million as of December 31, 2025 and December 31, 2024, respectively. 56,886 52,962
Class A Common Stock    
Stockholders’ equity (Deficit):    
Common stock 1 1
Treasury stock – at cost; 793 and 322 shares of Class A common stock as of December 31, 2025 and December 31, 2024, respectively. (9,371) (4,150)
Class B common stock    
Stockholders’ equity (Deficit):    
Common stock 1 1
Series A-1 convertible preferred stock    
Stockholders’ equity (Deficit):    
Preferred stock $ 0 $ 0